1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
685526A21130C14A865257EE700311520
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-medical-education-program-strategy-establishing-right-structures-resources-activities-optimize-biopharmaceutical-education-groups
18
19
2054.235.4.196
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Education

Best Practices in Medical Education Program Strategy: Establishing the Right Structures, Resources and Activities to Optimize Biopharmaceutical Education Groups

ID: POP-266


Features:

16 Info Graphics

30 Data Graphics

250+ Metrics

10 Narratives


Pages: 57


Published: 2015


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Medical education serves as a valuable platform for biopharmaceutical companies to inform physicians and health care professionals about the latest products, therapies, indications and treatment approaches. Also, it helps establish a company’s scientific credibility and reputation.


However, regulatory changes have tempered the sponsorship of some medical education programs by pharma companies, as well as some third-party providers of such services.

Best Practices, LLC, undertook this benchmarking study to investigate emerging Medical Education trends at biopharmaceutical organizations regarding funding and program types. The study also provides leading benchmarks around the proper size, resources, and structure for the Medical Education function.


Industries Profiled:
Biotech; Pharmaceutical; Health Care


Companies Profiled:
Acorda Therapeutics; Allergan; Astellas; AstraZeneca; Baxter BioScience; Boehringer Ingelheim; Daiichi Sankyo; Hospira; Lundbeck; Lupin; Pfizer; Upsher-Smith; UCB Pharma


Study Snapshot

Best Practices, LLC engaged 15 leaders supporting medical education at 13 leading life sciences companies. More than 50% of the participants are at the level of director/ senior director and around 20% of participants are managers. More than 80% of participants were from the United States.

Key Findings

1. Medical Education Structure Is Predominantly Centralized

More than three-fourths of pharma companies centralize their medical education structure; 46% of them have located their centralized medical education group in the United States.

2. Benchmark Companies Rely Heavily On Outsourcing

Pharma companies heavily rely on outsourcing for developing and deploying medical education programs. They outsource 86% of medical education program development to vendors, while they depend totally on vendors for program deployment and delivery.

Table of Contents

· Executive Summary, pgs. 3-13
· Research Overview, pg. 4
· Participating Companies, pg. 5
· Medical Education Landscape, pg. 6
· Changes In Medical Education Within The Last 2-3 Years, pg. 7
· Key Recommendations, pg. 8
· Key Findings & Insights, pgs. 9-12
· Dual Focus of Medical Education, pg. 13
· Structure & Activities, pgs. 14-19
· Professional Education Investment Level & Funding Sources, pgs. 20-31
· Professional Medical Education Staffing & Benchmark, pgs. 32-43
· Changing Trends & Directions For Medical Education, pgs. 44-50
· Benchmark Class Demographics, pgs. 51-55
· About Best Practices LLC, pgs. 56-57

List of Charts & Exhibits

· Structural Forces Creating Changes
· Medical Education Groups Organizational Fit
· Professional Medical Education Structural Approach
· Leadership & Scope
· Geographic Program Focus
· Program Content
· Resource Benchmarks
· Internal Funding Sources
· Budget Allocation Across Regions
· Budget Allocation by Program Type
· External Education Support Through Corporate Funding
· Cost Recovery Through Fee-for-Education Services
· Funding Allocations
· Global Staffing
· Budget Per FTE
· Program Development and Deployment – Insourced/Outsourced
· Span of Control (Number of staff per manager)
· Regional FTE Allocation
· Programs Supported By Professional Medical Education Group
· Grant Requests
· Programs per FTE
· Budget per Program
· Future Trends for Field-based Educators
· Reasons for Increasing/Decreasing Funding for CME Programs
· Investment Change Trends
· Funding Challenges
· Critical Success Factors
· Pitfalls/Obstacles To Avoid